In recent times, there has been a significant increase in researchers' interest in the functions
of microRNAs and the role of these molecules in the pathogenesis of many multifactorial …

Stroke is a major contributor to mortality and impairment on a global scale, with few effective
treatments available. Aberrant expression of various non-coding RNAs (ncRNAs) has been …

Neonatal Encephalopathy (NE) is a major cause of lifelong disability and neurological
complications in affected infants. Identifying novel diagnostic biomarkers in this population …

In the central nervous system (CNS), a large group of glial cells called astrocytes play
important roles in both physiological and disease conditions. Astrocytes participate in the …

Non-traumatic intracerebral hemorrhage (ICH) is the most common type of hemorrhagic
stroke, most often occurring between the ages of 45 and 60. Hypertension is most often the …

Current understanding of the mechanisms underlying central nervous system (CNS) injury is
limited, and traditional therapeutic methods lack a molecular approach either to prevent …

Stroke is a major cause of death and disability worldwide and is also a leading cause of
vascular dementia and Alzheimer's disease, with older women experiencing accelerated …

Stroke results in immediate sensory or motor disability and increases the risk for long term
cognitive-affective impairments. Thus, therapies are urgently needed to improve quality of …

Severe traumatic brain injury (sTBI) is an intracranial damage triggered by external force,
most commonly due to falls and traffic accidents. The initial brain injury can progress into a …

Acute ischemic stroke (AIS) is the leading cause of disability worldwide, and recanalization
therapy is significant in the hyperacute phase of AIS. However, reperfusion injury and …